amitriptyline has been researched along with fluoxetine in 240 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (10.83) | 18.7374 |
| 1990's | 78 (32.50) | 18.2507 |
| 2000's | 72 (30.00) | 29.6817 |
| 2010's | 50 (20.83) | 24.3611 |
| 2020's | 14 (5.83) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, VB; Geyer, HM; Kruse, H; Ong, HH; Profitt, JA; Wilker, JC | 1 |
| Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bosch, A; Del Castillo, JC; Del Río, J; Heras, B; Lasheras, B; Martínez-Esparza, J; Monge, A; Mourelle, M; Oficialdegui, AM; Orús, L; Palop, JA; Pérez-Silanes, S; Roca, J; Tordera, R | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Jia, L; Sun, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Arunotayanun, W; Dalley, JW; Gibbons, S; Huang, XP; Iversen, L; Roth, BL; Setola, V; Treble, R | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mishra, R; Sulser, F | 1 |
| Lauder, JM; Sadler, TW; Shuey, DL | 1 |
| Bertschy, G; Bizouard, P; Bonin, B; François, TH; Nezelof, S; Sechter, D; Vandel, B; Vandel, S | 1 |
| Dinan, TG; McLoughlin, D; O'Keane, V | 1 |
| Dubner, R; Lynch, SA; Max, MB; Muir, J; Shoaf, SE; Smoller, B | 1 |
| Arron, RJ; Bogdanovic, RP; Brandes, LJ; Fang, W; Hogg, GR; LaBella, FS; Tong, J; Warrington, RC; Zaborniak, CL | 1 |
| Marx, J | 1 |
| Brockmöller, J; Müller, N; Roots, I | 1 |
| Lauterbach, EC | 1 |
| Blackshaw, S; Boulton, AA; Bowen, RC; D'Arcy, C; Davis, BA; Dayal, N; Durden, DA; Keegan, DL; Remillard, AJ; Yu, PH | 2 |
| Burdon, AP; Crane, MU; Foulks, EF; Sutker, PB; Thompson, KE | 1 |
| Blackshaw, S; Boulton, A; Bowen, RC; Cebrian Perez, S; Dayal, N; Keegan, D; Remillard, F; Saleh, S; Shrikhande, S | 1 |
| Czarka, M; de Maertelaer, V; Kerkhofs, M; Linkowski, P; Mendlewicz, J; Rielaert, C | 1 |
| Iovino, M; Maj, M; Monteleone, P; Steardo, L | 1 |
| Johnston, H; March, JS; Moon, RL | 1 |
| Cohen, DL; Hanahoe, TH; Purcell, WM | 1 |
| Breitner, JC; Figiel, GS; Krishnan, KR; Nemeroff, CB | 1 |
| De Montigny, C; Desjardins, P; Desroches, J; Suranyi-Cadotte, BE; Welner, SA | 1 |
| Altamura, AC; De Novellis, F; Guercetti, G; Invernizzi, G; Montgomery, SA; Percudani, M | 1 |
| Altamura, AC; Guercetti, G; Invernizzi, G; Percudani, M | 1 |
| Allen, D; Lader, M | 1 |
| Blaschke, D; Engel, R; Laakmann, G; Schwarz, A | 1 |
| Allen, D; Curran, HV; Lader, M | 1 |
| Edwards, JG; Goldie, A; Upward, JW; Waller, DG | 1 |
| Davidson, RK; Dilsauer, SC; Hariharen, M | 1 |
| Burns, M; Moskowitz, H | 1 |
| Hindmarch, I | 1 |
| Coleman, A; Lader, MH; Young, JP | 1 |
| Bemis, KG; Bymaster, FP; Holland, DR; Smallwood, JK; Steinberg, MI | 1 |
| Ieni, JR; Meyerson, LR; Wennogle, LP | 1 |
| Andrews, P; Harder, A; Thomas, H | 1 |
| Fisch, C | 1 |
| Chouinard, G | 1 |
| Feighner, JP | 1 |
| Klimek, V; Kordecka-Magiera, A; Maj, J; Mogilnicka, E | 1 |
| Carter, RB; Leander, JD | 1 |
| Broekkamp, CL; Garrigou, D; Lloyd, KG | 1 |
| Aprison, MH; Hingtgen, JN; Nagayama, H | 1 |
| Marsden, CA; Stolz, JF | 1 |
| Arpino, C; Da Cas, R; Donini, G; Pasquini, P; Raschetti, R; Traversa, G | 1 |
| Goodwin, WB; Guyenet, PG; Huangfu, D | 1 |
| Crowson, AN; Magro, CM | 1 |
| Mathews, J | 1 |
| Barge-Schaapveld, DQ; De Vries, MW; Nicolson, NA; van der Hoop, RG | 1 |
| Benfield, P; Harris, MG | 1 |
| Lloyd, G; Lloyd, GG; Tobiansky, I; Tobiansky, RI | 1 |
| Gagiano, CA | 1 |
| Chaleby, K; el-Yazigi, A; Gad, A; Raines, DA | 1 |
| Hirschfeld, RM | 1 |
| Oesterheld, JR; Shader, RI | 1 |
| Nakielny, J | 1 |
| Nemecek, S | 1 |
| Boyeson, MG; Harmon, RL; Jones, JL | 1 |
| Fawcett, JP; Menkes, DB; Patel, PP | 1 |
| Blackshaw, SL; Bowen, RC; Cebrian-Perez, S; Dayal, N; Keegan, DL; Richardson, JS; Saleh, S; Shrikhande, S | 1 |
| Bellandi, F; Cantini, F; Di Munno, O; Niccoli, L | 1 |
| Brandt, DM; Szarek, BL | 1 |
| el-Yazigi, A; Raines, DA | 1 |
| Edwards, JG; Sedgwick, EM; Tarn, M | 1 |
| Beasley, CM; Potvin, JH; Sayler, ME | 1 |
| Potvin, JH; Souetre, E; Thomander, L; Tollefson, GD | 1 |
| Fairweather, DB; Hindmarch, I; Kerr, JS | 1 |
| Cadogan, AK; Kendall, DA; Marsden, CA; Tulloch, I | 1 |
| Burrows, GD; Gupta, RK; Judd, FK; Moore, K; Norman, TR; Parker, G | 1 |
| Miller, LG | 1 |
| Hambrecht, M | 1 |
| Hunter, KD; Wilson, WS | 1 |
| Baumann, P; Bertschy, G; Bizouard, P; Bonin, B; Bouquet, S; Francois, T; Sechter, D; Vandel, S | 1 |
| Erjavec, F; Ferjan, I | 1 |
| Naidu, MU; Prasad, VB; Rani, PU; Rao, TR; Shobha, JC | 1 |
| Lozet, H; Martin, P; Monteban, H; Souêtre, E | 1 |
| Mück-Weymann, M; Rechlin, T | 1 |
| Dziedzicka-Wasylewska, M; Maj, J; Rogoz, R; Rogóz, Z; Skuza, G | 1 |
| Einfeld, S; Levy, F; Looi, J | 1 |
| Jung, HY; Kwon, JS; Youn, T | 1 |
| Goldenberg, D; Mayskiy, M; Mossey, C; Ruthazer, R; Schmid, C | 1 |
| Johnson, SP | 1 |
| Daniel, WA; Wójcikowski, J | 3 |
| Kulkarni, SK; Kumar, S | 1 |
| Baker, B; Preskorn, SH | 1 |
| Lopukhov, IG | 1 |
| Aymard, G; Diquet, B; Livi, P; Pham, YT | 1 |
| Kamatchi, GL; Lynch, C; Pancrazio, JJ; Roscoe, AK | 1 |
| Fundaró, A | 1 |
| Caley, CF | 1 |
| Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa | 1 |
| Kovárů, H; Lisá, V; Lukásová, E; Rittich, B; Spanová, A | 1 |
| Ceccherininelli, A; Maggini, C; Marchesi, C; Rossi, A | 1 |
| Demyttenaere, K; Gaens, E; Gregoire, J; Mesters, P; Van Ganse, E | 1 |
| Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; von Moltke, LL | 1 |
| Akalin, O; Kurt, T; Oguzhanoglu, A; Sahiner, T | 1 |
| Esser, MJ; Reid, AR; Sawynok, J | 1 |
| Galin, RS; Robison, LM; Sclar, DA; Skaer, TL | 1 |
| Hakko, H; Jokelainen, J; Räsänen, P; Tiihonen, J | 1 |
| Dávila, J; Mata, S; Mazzotti, G; Ontiveros, A; Ospina, J; Pacheco, A; Palacios, M; Plewes, J; Tamura, R; Versiani, M | 1 |
| Brown, MC; Guest, JF; Nimmerrichter, AA | 1 |
| Caspi, D; Judovich, R; Levartovsky, D; Shirazi, I; Yaron, I; Yaron, M | 1 |
| Holsboer, F; Steckler, T; Uhr, M; Yassouridis, A | 1 |
| Ballester, R; Chuan, P; Domenech, C; Lluch, S; Medina, P; Segarra, G; Vila, JM | 1 |
| Sansone, RA; Shrader, JA; Wiederman, MW | 1 |
| Häggström, L; Nordling, S; Norinder, A | 1 |
| Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
| Amelin, AV; Gonchar, MA; Korenko, LA; Skoromets, AA; Tumelevich, BCh | 1 |
| Borghi, J; Guest, JF | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Alquier, P; Asfar, P; Boulet, S; Dube, L; Dupuis, JM; Rouleau, F; Victor, J | 1 |
| Barden, N; Beaulieu, S; Cyr, M; Di Paolo, T; Morissette, M; Rochford, J | 1 |
| Hanus, H; Hosák, L; Straka, L; Tůma, I | 1 |
| Pick, CG; Schreiber, S; Shavelzon, V; Shir, Y; Vinokur, S; Zahavi, E | 1 |
| Boulanger, B; Delsemme, MH; Demyttenaere, K; Dewe, W; Gregoire, J; Mesters, P; Van Ganse, E | 1 |
| Daniel, WA; Pałucha, A; Wójcikowski, J | 1 |
| Henry, W; McGurk, C; Wilson, D | 1 |
| Hensler, JG | 1 |
| Bartholomä, P; Baumann, B; Erlandsson, N; Giehl, KM; Kaufmann, K; Rössler, OG; Thiel, G; Wirth, T | 1 |
| Morsch, VM; Müller, TC; Neis, RT; Rocha, JB; Schetinger, MR | 1 |
| Garrido Barral, A; González Moneo, MJ | 1 |
| Alves, LA; Barbosa, JS; Krymchantowski, AV; Silva, MT | 1 |
| Diaz, A; Fouilloux, C; Ortiz, S | 1 |
| van de Laar, MA; Zijlstra, TR | 1 |
| Kazlauskas, S; Kazlauskiene, D; Vainauskas, P | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Califf, RM; Curtis, LH; Dans, PE; Hutchison, S; Schulman, KA; Sendersky, V; Usdin Yasuda, S; Woosley, RL; Wright, A; Østbye, T | 1 |
| Banti, S; Borri, C; Camilleri, V; Cassano, GB; Mauri, M; Miniati, M; Pini, S; Rotondo, A | 1 |
| Müller, W; Stratz, T; Varga, B | 1 |
| Chapman, KE; Kelly, PA; Lai, M; McCormick, JA; Seckl, JR; Yau, JL | 1 |
| Chan, W; Yen, HL | 1 |
| Abdel-Salam, OM; El-Shenawy, SM; Nofal, SM | 1 |
| Abbott, R; Cornwall, PL; Garland, A; Hayhurst, H; Jenaway, A; Johnson, AL; Moore, R; Paykel, ES; Pope, M; Scott, J; Teasdale, JD | 1 |
| Amelin, AV; Ignatov, IuD; Skoromets, AA | 1 |
| Kazlauskiene, D; Rakauskaite, D; Vainauskas, P | 1 |
| Kazlauskiene, D; Kiliuviene, G; Marksiene, R; Vainauskas, P | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Jick, H; Jick, SS; Kaye, JA | 1 |
| Bellissant, E; Dinasquet, M; Reymann, JM; Sébille, V; Siproudhis, L | 1 |
| Fricker, G; Kressmann, S; Müller, WE; Weber, CC | 1 |
| Barbui, C | 1 |
| Kolla, N; Li, XM; Richardson, JS; Wei, Z | 1 |
| Goldney, RD | 1 |
| Arenas, MC; Everss, E; Ferrer-Añó, A; Martos, AJ; Monleón, S; Parra, A; Vinader-Caerols, C | 1 |
| Gökbel, H; Levendoğlu, F; Okudan, N; Ozerbil, O | 1 |
| Davies, PS; Fields, HL; Reisner, LA; Rowbotham, MC | 1 |
| Barbui, C; Brambilla, P; Cipriani, A; Furukawa, TA; Watanabe, N | 1 |
| Duric, V; Enna, SJ; McCarson, KE; Reisman, SA; Winter, M | 1 |
| Bartels, M; Buchkremer, G; Eschweiler, GW; Klein, R; Köhler, N; Laske, C; Leyhe, T; Richartz, E; Schott, K; Stransky, E; Wittorf, A | 1 |
| Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS | 1 |
| Feuer, JM; Fischer, PA; Goldenberg, DL; Kieval, RI; Mogavero, N; Rapoport, RJ; Ruthazer, R; Schmid, CH; Selker, HP; Stotsky, SA; Winston, E; Zucker, DR | 1 |
| Cheng, G; Kong, LD; Pan, Y; Xia, X; Xia, ZH | 1 |
| Dingwall, K; Douglas, J; Jorgenson, G; Smith, SS | 1 |
| Gross, G; Groth, I; Jongen-Relo, A; Rex, A; Wicke, KM | 1 |
| Frank, JG; Keller, A; Nuwayhid, SJ; Werling, LL | 1 |
| Duman, RS; Gourley, SL; Kedves, AT; Kiraly, DD; Ploski, JE; Taylor, JR; Wu, FJ | 1 |
| Jürgens, TP; Koch, HJ; Leinisch, E | 1 |
| Enginar, N; Firtina, M; Hatipoğlu, I | 1 |
| Adams, SM | 1 |
| Ayers, DM; Durieux, ME; Johannes, T; Ploppa, A; Unertl, KE | 1 |
| Diaz-Rojas, J; Einarson, TR; Jaramillo, LE; Lopera, MM; Machado, M | 1 |
| Han, YS; Lee, CS | 1 |
| Billups, SJ; Delate, T; Dugan, D | 1 |
| Burslem, K; Greenstreet, L; Knight, C; Lenox-Smith, A | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Licinio, J; Mastronardi, CA; Reierson, GW; Wong, ML | 1 |
| Klodt, PM; Kudrin, VS; Molodavkin, GM; Mosin, VM; Narkevich, VB; Voronina, TA | 1 |
| Chen, CC; Gerner, P; Huang, CJ; Hung, YC; Pan, YY; Srinavasan, V; Suzuki, S; Wang, CF | 1 |
| Ferrer-Añó, A; Fuentes, C; Monleón, S; Parra, A; Vinader-Caerols, C | 1 |
| Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Ruthazer, R; Schmid, CH; Zucker, DR | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Andjelkovic, M; Jankovic, SM; Jovanovic, DB; Zdravkovic, N | 1 |
| Linderoth, B; Meyerson, BA; Song, Z | 1 |
| Gurel, V; Knopik, VS; McGeary, JE; McMichael, J; Spaulding, J | 1 |
| Bleich, S; Frieling, H; Herbst, D; Nedeljkov, V; Nedeljkov-Jancic, R; Pavlovic, D; Ribback, S; Wendt, M | 1 |
| Alonso, E; Dorado, P; Jung, H; Llerena, A; López-López, M; Naranjo, ME; Ortega, A; Peñas-Lledó, EM; Trejo, HD | 1 |
| Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
| Coleman, HM; Khan, SJ; Le-Clech, P; Stuetz, RM; Trinh, T; van den Akker, B | 1 |
| Edwards, MJ; Gulbins, E; Henry, B; Lentsch, AB; Ziobro, R | 1 |
| Clarke, G; Cryan, JF; Dinan, TG; Griffin, BT; O'Brien, FE | 1 |
| Eibak, LE; Gjelstad, A; Parmer, MP; Pedersen-Bjergaard, S; Rasmussen, KE | 1 |
| Bączek, T; Biernacki, M; Dziomba, S; Kowalski, P; Olędzka, I; Skrzydlewska, E | 1 |
| Eibak, LE; Gjelstad, A; Oiestad, EL; Pedersen-Bjergaard, S; Rasmussen, KE | 1 |
| Eren Cevik, S; Guneysel, O; Tasyurek, T | 1 |
| Derry, S; Hearn, L; Moore, RA; Phillips, T; Wiffen, PJ | 1 |
| Makuch, W; Mika, J; Przewlocka, B; Rojewska, E; Zychowska, M | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Kalinina, TS; Kudryashov, NV; Voronina, TA | 1 |
| Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
| Chen, M; Hoshino, H; Obata, H; Saito, S; Yang, Y | 1 |
| Hu, L; Lei, P; Liu, S; Pan, C; Qu, H; Shen, Y; Wu, M; Yang, M | 1 |
| Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ | 1 |
| Guo, D; Guo, J; Huang, S; Li, Q; Polli, JE; Shu, Y; Xiong, Z; Ye, Z; Zhang, W; Zhou, H; Zhu, P | 1 |
| Feng, S; Gu, J; Jiang, X; Tang, S; Wang, L; Zheng, L | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Badura, J; Chelminiak, Z; Cuprys, M; Fraczek, J; Koszla, O; Koziorowski, M; Mytych, J; Solek, P; Tabecka-Lonczynska, A | 1 |
| Akinci, M; Canbaz, S; Gunduz, O; Huseyin, S; Karadag, CH; Oltulu, C; Topuz, RD | 1 |
| Gneushev, ET; Kondratenko, SN; Kukes, VG; Savelyeva, MI; Shikh, EV | 1 |
| Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L | 1 |
| Feng, C; Lei, B; Peng, W; Tang, Q; Xu, L; Zhang, X | 1 |
| Qu, W; Wang, H; Yan, H; Zhang, W | 1 |
| Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A | 1 |
| Bernardo, CO; Gonzalez-Chica, DA; Jureidini, J; Klau, J; Raven, M | 1 |
| Eryilmaz, M; Gurpinar, SS; Kart, D | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Börger, V; Bromkamp, C; Doeppner, TR; Giebel, B; Gulbins, E; Gunzer, M; Hagemann, N; Hasenberg, M; Hermann, DM; Hussner, T; Kleinschnitz, C; Kleuser, B; Kolesnick, R; Martiny, C; Mohamud Yusuf, A; Schumacher, F; Sickmann, A; Solari, FA; Tertel, T; Zafar, M; Zhang, X | 1 |
| Chen, KY; Li, RY | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Choy, JS; Elizalde, P; Guo, HB; Ou, J; Qin, H; Tobe, BTD | 1 |
| Gaynes, BN; Hosseinipour, MC; Kulisewa, K; Minnick, CE; Mphonda, S; Pence, BW; Sansbury, G; Stockton, MA; Udedi, MM | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
| Alymov, AA; Kapitsa, IG; Savinkova, EV; Seredenin, SB; Voronina, TA | 1 |
| Aydın, Ş; Çivgin, ME; Dinçer Öner, S; Kılıç Tatlıcı, C; Kılıç, FS; Yazıcı, ZG; Yıldırım, C | 1 |
18 review(s) available for amitriptyline and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
Topics: Aged; Amitriptyline; Clomipramine; Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Receptors, Adrenergic; Suicide | 1995 |
Guidelines for the long-term treatment of depression.
Topics: Adult; Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Middle Aged; Paroxetine; Placebos; Psychotherapy; Recurrence; Time Factors; Treatment Outcome | 1994 |
Extrapolating in vitro data on drug metabolism to in vivo pharmacokinetics: evaluation of the pharmacokinetic interaction between amitriptyline and fluoxetine.
Topics: Amitriptyline; Antidepressive Agents; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Humans; Models, Biological | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
[Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective].
Topics: Adrenergic alpha-Agonists; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost of Illness; Cost-Benefit Analysis; Depression; Drug Costs; Fluoxetine; Histamine H1 Antagonists; Humans; Mianserin; Mirtazapine; Models, Economic; Socioeconomic Factors; Sweden | 2000 |
Diagnosing fibromyalgia.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Cognitive Behavioral Therapy; Fibromyalgia; Fluoxetine; Humans; Pain Management; Selective Serotonin Reuptake Inhibitors | 2001 |
[Latest therapies for treating dementia].
Topics: Adult; Aged; Alzheimer Disease; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Cognition; Cohort Studies; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Female; Fluoxetine; Galantamine; Haloperidol; Hormone Replacement Therapy; Humans; Hydroxychloroquine; Indans; Middle Aged; Nootropic Agents; Piperidines; Placebos; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Trazodone | 2002 |
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Clonidine; Fluoxetine; Humans; Imidazoles; Maprotiline; Methysergide; Migraine Disorders; Mutation; Pizotyline; Placebos; Propranolol; Research; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sympatholytics; Vasoconstrictor Agents | 2003 |
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Cyclohexanols; Depression; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Fluoxetine; Humans; Migraine Disorders; Polypharmacy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2008 |
Desipramine for neuropathic pain in adults.
Topics: Aged; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Chronic Pain; Clomipramine; Desipramine; Diabetic Neuropathies; Fluoxetine; Humans; Middle Aged; Neuralgia, Postherpetic; Randomized Controlled Trials as Topic | 2014 |
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Syndrome | 2015 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Benzodiazepines; Carisoprodol; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Fluoxetine; Humans; Magnesium; Malates; Melatonin; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Pregabalin; Randomized Controlled Trials as Topic | 2018 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Carbamazepine; Duloxetine Hydrochloride; Fluoxetine; Gabapentin; Humans; Lamotrigine; Multicenter Studies as Topic; Network Meta-Analysis; Neuralgia; Pregabalin; Randomized Controlled Trials as Topic; Vitamins | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
44 trial(s) available for amitriptyline and fluoxetine
| Article | Year |
|---|---|
D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
Topics: Adolescent; Adult; Amitriptyline; Depressive Disorder; Electroconvulsive Therapy; Female; Fenfluramine; Fluoxetine; Humans; Hydrocortisone; Male; Middle Aged; Personality Inventory; Prognosis; Prolactin; Receptors, Serotonin; Serotonin | 1992 |
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analgesics; Depression; Desipramine; Diabetic Neuropathies; Double-Blind Method; Female; Fluoxetine; Humans; Infant, Newborn; Male; Middle Aged; Pain | 1992 |
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Personality Tests; Phenylacetates; Psychiatric Status Rating Scales | 1991 |
A comparison of fluoxetine and amitriptyline in the treatment of major depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1991 |
Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables.
Topics: Adolescent; Adult; Amitriptyline; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sleep | 1990 |
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
Topics: Aged; Amitriptyline; Appetite; Body Weight; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic | 1989 |
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline.
Topics: Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Random Allocation; Weight Gain | 1989 |
Interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects.
Topics: Amitriptyline; Double-Blind Method; Drug Interactions; Electroencephalography; Emotions; Ethanol; Female; Fluoxetine; Humans; Male; Psychomotor Performance | 1989 |
Fluoxetine vs amitriptyline in the treatment of depressed out-patients.
Topics: Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Time Factors | 1988 |
A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects.
Topics: Alcohol Drinking; Amitriptyline; Arousal; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Ethanol; Evoked Potentials; Female; Fluoxetine; Humans; Male; Mental Processes; Propylamines | 1988 |
Comparative effects of fluoxetine and amitriptyline on cardiac function.
Topics: Adult; Amitriptyline; Blood Pressure; Electrocardiography; Female; Fluoxetine; Heart; Humans; Male; Middle Aged | 1988 |
The effects on performance of two antidepressants, alone and in combination with diazepam.
Topics: Adult; Amitriptyline; Attention; Diazepam; Drug Interactions; Fluoxetine; Humans; Male; Memory; Psychological Tests; Reference Values | 1988 |
A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.
Topics: Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Propylamines; Random Allocation | 1987 |
A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Amitriptyline; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Disorder; Dizziness; Female; Fluoxetine; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Placebos; Propylamines; Psychiatric Status Rating Scales; Tremor; Xerostomia | 1985 |
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Topics: Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Nausea; Propylamines; Psychiatric Status Rating Scales; Random Allocation; Sleep Stages; Xerostomia | 1985 |
Changes in daily life experience associated with clinical improvement in depression.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Amitriptyline; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Motivation; Personality Inventory; Quality of Life; Single-Blind Method | 1995 |
Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone.
Topics: Adolescent; Adult; Amitriptyline; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nortriptyline | 1995 |
Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline.
Topics: Adolescent; Adult; Aged; Amitriptyline; Animals; Brain; Depressive Disorder; Female; Fluoxetine; Humans; Male; Memory, Short-Term; Mental Recall; Middle Aged; Quinuclidinyl Benzilate; Rats; Receptors, Muscarinic; Verbal Learning | 1994 |
[Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia].
Topics: Adult; Amitriptyline; Drug Therapy, Combination; Female; Fibromyalgia; Fluoxetine; Humans; Middle Aged; Muscle Relaxants, Central; Time Factors | 1994 |
Fluoxetine, amitriptyline and the electroencephalogram.
Topics: Adult; Alpha Rhythm; Amitriptyline; Beta Rhythm; Brain; Delta Rhythm; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Theta Rhythm | 1993 |
Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome | 1993 |
Effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients.
Topics: Aged; Amitriptyline; Cognition; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Mental Recall; Neuropsychological Tests; Personality Inventory; Psychomotor Performance; Reaction Time; Sleep Stages | 1993 |
A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness.
Topics: Adult; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Suicide; Suicide Prevention | 1993 |
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Pharmacogenetics; Phenotype | 1995 |
An evaluation of antidepressants in rheumatic pain conditions.
Topics: Adult; Amitriptyline; Analgesics; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Double-Blind Method; Female; Fluoxetine; Humans; Incidence; Male; Pain; Pain Measurement; Placebos; Rheumatic Diseases; Safety; Selective Serotonin Reuptake Inhibitors; Xerostomia | 1996 |
Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cerebral Cortex; Depressive Disorder; Dominance, Cerebral; Dose-Response Relationship, Drug; Electroencephalography; Female; Fluoxetine; Fourier Analysis; Humans; Male; Middle Aged; Signal Processing, Computer-Assisted; Treatment Outcome | 1996 |
A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia.
Topics: Adolescent; Adult; Amitriptyline; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1996 |
Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1998 |
Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Patient Compliance; Treatment Outcome | 1998 |
Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches.
Topics: Adult; Amitriptyline; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Migraine Disorders; Tension-Type Headache; Treatment Outcome | 1999 |
Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales | 1999 |
Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Austria; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; Drug Hypersensitivity; Fluoxetine; Humans; Mianserin; Mirtazapine; Retrospective Studies; Severity of Illness Index | 1999 |
[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Analgesics, Non-Narcotic; Female; Fluoxetine; Humans; Male; Maprotiline; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain.
Topics: Adolescent; Adult; Aged; Amitriptyline; Female; Fluoxetine; Humans; Low Back Pain; Male; Middle Aged; Neck Pain; Pain Measurement; Prospective Studies; Single-Blind Method; Whiplash Injuries | 2001 |
Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine.
Topics: Adult; Amitriptyline; Double-Blind Method; Drug Monitoring; Female; Fluoxetine; Humans; Male; Middle Aged; Patient Compliance; Patient Dropouts; Risk | 2001 |
Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heartburn; Humans; Male; Middle Aged; Migraine Disorders; Prospective Studies; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2002 |
Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Topics: Adolescent; Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive Disorder; Diazepam; Drug Combinations; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Perphenazine; Prospective Studies; Psychiatric Status Rating Scales | 2002 |
Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Anorexia Nervosa; Body Mass Index; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2003 |
[The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia].
Topics: Adjustment Disorders; Administration, Oral; Adult; Amitriptyline; Depressive Disorder; Drug Therapy, Combination; Female; Fibromyalgia; Fluoxetine; Humans; Indoles; Injections, Intravenous; Middle Aged; Pain Measurement; Personality Inventory; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Sick Role; Treatment Outcome; Tropisetron | 2003 |
Prevention of relapse in residual depression by cognitive therapy: a controlled trial.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Secondary Prevention; Treatment Outcome | 1999 |
Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception.
Topics: Adolescent; Adult; Amitriptyline; Anal Canal; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Fluoxetine; Gastrointestinal Motility; Humans; Male; Manometry; Perception; Viscera | 2004 |
Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cross-Over Studies; Double-Blind Method; Exercise Test; Fatigue; Female; Fibromyalgia; Fluoxetine; Humans; Middle Aged | 2006 |
Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Patient Dropouts; Treatment Outcome | 2005 |
Gallbladder emptying in patients with major depression: a case series.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Case-Control Studies; Depressive Disorder, Major; Female; Fluoxetine; Gallbladder; Gallbladder Emptying; Humans; Male; Maprotiline; Middle Aged; Organ Size; Ultrasonography | 2011 |
179 other study(ies) available for amitriptyline and fluoxetine
| Article | Year |
|---|---|
Novel tetracyclic spiropiperidines. 1. 3-Aryl-1,3-dihydrospiro[benzo[c]thiophene-1,4'-piperidines] as potential antidepressants.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Tricyclic; Blepharoptosis; Chemical Phenomena; Chemistry; Drug Synergism; Male; Mice; Physostigmine; Piperidines; Spiro Compounds; Tetrabenazine | 1981 |
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Carrier Proteins; Colony-Forming Units Assay; Conditioning, Operant; Cyclic AMP; HeLa Cells; Humans; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Piperazines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiophenes | 2001 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.
Topics: Allyl Compounds; HEK293 Cells; Humans; Indoles; Magnetic Resonance Spectroscopy; Molecular Conformation; Propylamines; Protein Binding; Psychotropic Drugs; Receptors, Serotonin; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Tryptamines | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
Topics: Adenylyl Cyclases; Amitriptyline; Animals; Brain; Clomipramine; Dibenzazepines; Fluoxetine; Male; Norepinephrine; Propylamines; Rats; Serotonin | 1978 |
Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Amitriptyline; Animals; Cell Death; Cell Division; Epithelium; Facial Bones; Female; Fluoxetine; Mice; Mice, Inbred ICR; Morphogenesis; Pinocytosis; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Skull; Yolk Sac | 1992 |
Tricyclic antidepressant plasma levels after fluoxetine addition.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged | 1992 |
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Amitriptyline; Animals; Antidepressive Agents; DNA; Fluoxetine; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms, Experimental | 1992 |
Do antidepressants promote tumors?
Topics: Amitriptyline; Animals; Breast Neoplasms; Carcinogens; Female; Fluoxetine; Humans; Mice; Neoplasms, Experimental; Rats; Tamoxifen; United States; United States Food and Drug Administration | 1992 |
Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele--a slowly reversible interaction with fluoxetine.
Topics: Alleles; Amitriptyline; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Half-Life; Humans; Middle Aged; Nortriptyline; Phenotype; Spectrophotometry, Ultraviolet | 1991 |
Serotonin reuptake inhibitors, paranoia, and the ventral basal ganglia.
Topics: Adult; Amitriptyline; Antidepressive Agents; Basal Ganglia; Female; Fluoxetine; Humans; Male; Neurotransmitter Uptake Inhibitors; Paranoid Disorders; Serotonin Antagonists | 1991 |
Deuterium-labelled p-tyramine challenge test and phenolsulfotransferase activity in depressed patients--failure to replicate decreased p-tyramine conjugation in depression.
Topics: Amitriptyline; Arylsulfotransferase; Chromatography, Thin Layer; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Tyramine | 1991 |
Pilot program of treatment for PTSD.
Topics: Amitriptyline; Behavior Therapy; Combined Modality Therapy; Family Therapy; Fluoxetine; Humans; Male; Pilot Projects; Psychotherapy; Psychotropic Drugs; Stress Disorders, Post-Traumatic | 1991 |
GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach.
Topics: Adult; Amitriptyline; Antidepressive Agents; Baclofen; Brain; Depressive Disorder; Fluoxetine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Imipramine; Male; Middle Aged; Personality Tests; Receptors, GABA-A | 1990 |
Fluoxetine-TCA interaction.
Topics: Amitriptyline; Child; Depressive Disorder; Drug Synergism; Fluoxetine; Humans; Male | 1990 |
Contribution of post-secretory mechanisms to the observed pattern of histamine and 5-hydroxytryptamine secretion from peritoneal rat mast cells in response to compound 48/80.
Topics: Amitriptyline; Animals; Biological Transport; Cell Separation; Clomipramine; Female; Fluoxetine; Histamine; Histamine Release; Mast Cells; Nialamide; Pargyline; Peritoneal Cavity; Phosphatidylserines; Rats; Rats, Inbred Strains; Secretory Rate; Serotonin; Temperature | 1989 |
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases; Delirium; Depressive Disorder; Female; Fluoxetine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nortriptyline; Risk Factors; Trazodone | 1989 |
Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amitriptyline; Animals; Antidepressive Agents; Brain; Fluoxetine; Male; Rats; Receptors, Serotonin; Tetrahydronaphthalenes | 1989 |
Desipramine subsensitizes nicotinic mechanism involved in regulating core temperature.
Topics: Amitriptyline; Animals; Body Temperature Regulation; Brain; Desipramine; Fluoxetine; Light; Lithium; Male; Nicotine; Phenelzine; Rats; Rats, Inbred Strains; Receptors, Nicotinic | 1988 |
A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability.
Topics: Adult; Amitriptyline; Automobile Driving; Dothiepin; Female; Flicker Fusion; Fluoxetine; Humans; Psychomotor Performance; Reaction Time | 1988 |
Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs.
Topics: Amitriptyline; Animals; Cardiac Output; Dogs; Electrocardiography; Female; Fluoxetine; Heart Rate; Hemodynamics; Male; Propylamines; Serotonin; Stroke Volume; Vascular Resistance | 1986 |
Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
Topics: Amitriptyline; Blood Platelets; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlorpromazine; Ethylmaleimide; Fluoxetine; Humans; Imipramine; Kinetics; Pyrilamine; Receptors, Serotonin | 1987 |
Chlorpromazine, other amphiphilic cationic drugs and praziquantel: effects on carbohydrate metabolism of Schistosoma mansoni.
Topics: Amitriptyline; Animals; Carbohydrate Metabolism; Chlorpromazine; Fluoxetine; Glucose; Imipramine; Lactates; Praziquantel; Propranolol; Schistosoma mansoni | 1987 |
Effect of fluoxetine on the electrocardiogram.
Topics: Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents; Arrhythmias, Cardiac; Bundle-Branch Block; Doxepin; Electrocardiography; Female; Fluoxetine; Heart; Heart Conduction System; Heart Rate; Humans; Imipramine; Male; Middle Aged; Propylamines; Retrospective Studies | 1985 |
Chronic treatment with antidepressants: protentiation of clonidine-induced aggression in mice via noradrenergic mechanism.
Topics: Aggression; Amitriptyline; Animals; Antidepressive Agents; Brompheniramine; Clonidine; Drug Synergism; Fluoxetine; Humans; Male; Maprotiline; Mice; Zimeldine | 1981 |
Effects of norepinephrine and serotonin uptake inhibitors on the schedule-controlled behavior of the pigeon.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Clomipramine; Columbidae; Conditioning, Operant; Desipramine; Doxepin; Fluoxetine; Iprindole; Male; Norepinephrine; Protriptyline; Reinforcement Schedule; Serotonin Antagonists | 1984 |
Involvement of the amygdala in the effect of antidepressants on the passive avoidance deficit in bulbectomised rats.
Topics: Amitriptyline; Amygdala; Animals; Antidepressive Agents; Avoidance Learning; Fluoxetine; Imipramine; Male; Metergoline; Norepinephrine; Olfactory Bulb; Rats; Serotonin | 1981 |
Pre- and postsynaptic serotonergic manipulations in an animal model of depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Depression; Disease Models, Animal; Drug Synergism; Fluoxetine; Humans; Male; Methysergide; Propylamines; Rats; Serotonin | 1980 |
Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline.
Topics: Amitriptyline; Animals; Ergolines; Fluoxetine; Male; Metergoline; Motor Activity; Propranolol; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1981 |
Use and misuse of antidepressant drugs in a random sample of the population of Rome, Italy.
Topics: Amitriptyline; Antidepressive Agents; Cross-Sectional Studies; Depressive Disorder; Drug Administration Schedule; Drug Prescriptions; Drug Utilization; Female; Fluoxetine; Health Services Misuse; Humans; Incidence; Male; Patient Care Team; Rome; S-Adenosylmethionine; Sampling Studies; Urban Population | 1995 |
Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats.
Topics: Adrenergic alpha-Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Baclofen; Blood Pressure; Brain Mapping; Desipramine; Dioxanes; Fluoxetine; gamma-Aminobutyric Acid; Idazoxan; Imidazoles; Male; Medulla Oblongata; Microinjections; Nordefrin; Oxidopamine; Rats; Rats, Sprague-Dawley; Splanchnic Nerves; Sympatholytics; Time Factors | 1995 |
Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia.
Topics: Adult; Aged; Amitriptyline; Drug Eruptions; Female; Fluoxetine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Middle Aged; Skin; Skin Diseases | 1995 |
Concern over Prozac-induced tumor growth may dwindle following FDA study.
Topics: Amitriptyline; Animals; Depression; Fluoxetine; Humans; Loratadine; Neoplasms; Recurrence; United States; United States Food and Drug Administration | 1995 |
ECT seizure threshold and fluoxetine.
Topics: Amitriptyline; Combined Modality Therapy; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium Carbonate; Male; Middle Aged; Seizures | 1995 |
[Fluoxetine in perspective].
Topics: Amitriptyline; Depression; Double-Blind Method; Fluoxetine; Humans; Paroxetine | 1994 |
Case 2: Dizzy Giuseppi or the vertiginous virtuoso.
Topics: Aged; Amitriptyline; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Male | 1994 |
Seizures and antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Risk Factors; Seizures | 1994 |
Backfire. Could Prozac and Elavil promote tumor growth?
Topics: Amitriptyline; Animals; Female; Fluoxetine; Humans; Male; Mammary Neoplasms, Animal | 1994 |
Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury.
Topics: Amitriptyline; Brain Injuries; Fluoxetine; Motor Cortex; Psychomotor Performance; Serotonin; Time Factors | 1994 |
Antidepressant treatment and chemical sympathectomy fail to modulate alpha 1-adrenoceptor sensitivity in mouse eye.
Topics: Administration, Topical; Amitriptyline; Animals; Antidepressive Agents; Benzamides; Desipramine; Down-Regulation; Fluoxetine; Injections, Intraperitoneal; Male; Methoxamine; Mice; Moclobemide; Oxidopamine; Phentolamine; Phenylephrine; Prazosin; Pupil; Receptors, Adrenergic, alpha-1; Sympathectomy, Chemical; Time Factors | 1993 |
A comparison of weight changes with fluoxetine, desipramine, and amitriptyline: a retrospective study of psychiatric inpatients.
Topics: Amitriptyline; Body Weight; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Hospitalization; Humans; Male; Mental Disorders; Retrospective Studies; Weight Gain | 1993 |
Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Desipramine; Fluoxetine; Humans; Imipramine; Indicators and Reagents; Nortriptyline; Spectrophotometry, Ultraviolet | 1993 |
Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes.
Topics: Absenteeism; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Comorbidity; Cost of Illness; Cross-Sectional Studies; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Work Capacity Evaluation | 1993 |
Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
Topics: Amitriptyline; Animals; Brain Chemistry; Calcimycin; Calcium; Cerebral Cortex; Female; Fluoxetine; Guinea Pigs; In Vitro Techniques; Inositol; Ketanserin; Male; Paroxetine; Phosphatidylinositols; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1993 |
Antidepressants and cancer: cause for concern?
Topics: Amitriptyline; Animals; Antidepressive Agents; Cocarcinogenesis; Depressive Disorder; Fluoxetine; Humans; Mice; Neoplasms; Rats; Risk Factors | 1993 |
[Toxic tricyclic drug plasma level caused by fluoxetine].
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Heart Block; Humans; Metabolic Clearance Rate; Middle Aged; Nortriptyline; Recurrence | 1995 |
The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Muscarinic Antagonists; Parotid Gland; Paroxetine; Potassium; Prospective Studies; Receptors, Muscarinic; Retrospective Studies; Saliva; Secretory Rate; Selective Serotonin Reuptake Inhibitors; Sodium; Xerostomia | 1995 |
Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Calcium; Clomipramine; Fluoxetine; Histamine Release; Mast Cells; p-Methoxy-N-methylphenethylamine; Peritoneum; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Fluoxetine; France; Humans; Male; Middle Aged; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 1996 |
Reflexes of the cutaneous microcirculation in amitriptyline and in fluoxetine treated patients.
Topics: Adult; Amitriptyline; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Reflex; Skin | 1996 |
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Corpus Striatum; Dopamine Agonists; Fluoxetine; Imipramine; Limbic System; Male; Mianserin; Protein Binding; Rats; Rats, Wistar; Receptors, Dopamine D2; Synaptic Membranes; Tetrahydronaphthalenes; Thiophenes; Up-Regulation | 1996 |
Combined pharmacotherapy or polypharmacy?
Topics: Aggression; Akathisia, Drug-Induced; Amitriptyline; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Drug Therapy, Combination; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin | 1996 |
Fluoxetine and amitriptyline in the treatment of fibromyalgia.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Double-Blind Method; Drug Therapy, Combination; Fibromyalgia; Fluoxetine; Humans; Middle Aged; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1997 |
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 1997 |
Influence of antidepressant drugs on learning and memory paradigms in mice.
Topics: Aged; Amitriptyline; Animals; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Imipramine; Learning; Male; Memory; Mice; Muscarinic Antagonists; Scopolamine | 1996 |
Fatality associated with combined fluoxetine-amitriptyline therapy.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Drug Interactions; Drug Therapy, Combination; Fatal Outcome; Fluoxetine; Humans; Male | 1997 |
[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Evaluation; Female; Fluoxetine; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Time Factors | 1997 |
Sensitive and rapid method for the simultaneous quantification of five antidepressants with their respective metabolites in plasma using high-performance liquid chromatography with diode-array detection.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Clomipramine; Fluoxetine; Humans; Imipramine; Maprotiline; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1997 |
Inhibition of neuronal Na+ channels by antidepressant drugs.
Topics: Amitriptyline; Animals; Antidepressive Agents; Cattle; Dose-Response Relationship, Drug; Fluoxetine; Ganglia, Spinal; Rats; Sodium Channel Blockers | 1998 |
Interactions between promazine and antidepressants at the level of cellular distribution.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline | 1997 |
Pinch-induced catalepsy in mice: a useful model to investigate antidepressant or anxiolytic drugs.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Catalepsy; Female; Fluoxetine; Fluvoxamine; Imipramine; Learning; Male; Mice; Models, Psychological; Motor Activity; Ondansetron; Physical Stimulation; Reaction Time; Serotonin Antagonists; Sex Characteristics; Stereotyped Behavior | 1998 |
Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors | 1998 |
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
Estimation of apoptosis in C6 glioma cells treated with antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Apoptosis; DNA Fragmentation; Fluoxetine; Glioma; Humans; Imipramine; Tumor Cells, Cultured | 1997 |
Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclopropanes; Drug Evaluation; Europe; Fluoxetine; Fluvoxamine; Humans; Imipramine; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States | 1998 |
The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.
Topics: Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoxetine; Imipramine; In Vitro Techniques; Lysosomes; Male; Monensin; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Thioridazine | 1999 |
Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Caffeine; Desipramine; Drug Evaluation, Preclinical; Fluoxetine; Male; Neuralgia; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Spinal Nerves | 1999 |
Economic appraisal of citalopram in the management of single-episode depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline | 1999 |
Outcome of different types of long-term antidepressant treatments: a 3-year follow-up study of 14182 patients.
Topics: Adult; Amitriptyline; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Treatment Outcome | 1999 |
Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures.
Topics: Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Culture Techniques; Dinoprostone; Female; Fluoxetine; Glycosaminoglycans; Humans; Hyaluronic Acid; Male; Nitric Oxide; Sulfur Radioisotopes; Synovial Membrane | 1999 |
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Male; Mice; Mice, Knockout | 2000 |
Effects of antidepressants in adrenergic neurotransmission of human vas deferens.
Topics: Amitriptyline; Antidepressive Agents; Calcium; Calcium Channel Blockers; Culture Techniques; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Muscle Contraction; Nifedipine; Receptors, Adrenergic; Sertraline; Synaptic Transmission; Vas Deferens | 2000 |
Naturalistic study of the weight effects of amitriptyline, fluoxetine, and sertraline in an outpatient medical setting.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Female; Fluoxetine; Humans; Male; Middle Aged; Retrospective Studies; Sertraline; Weight Gain | 2000 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |
Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Mianserin; Middle Aged; Mirtazapine; Severity of Illness Index; United Kingdom | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Female; Fluoxetine; Heart; Humans; Male; Middle Aged; Phenothiazines; Psychotropic Drugs; Syndrome; Time Factors | 2001 |
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Binding Sites; Carrier Proteins; Depression; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Transgenic; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Glucocorticoid; Stress, Physiological; Substantia Nigra | 2001 |
Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Citalopram; Czech Republic; Depressive Disorder; Drug Costs; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome | 2000 |
Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping.
Topics: Amitriptyline; Animals; Astrocytes; Brain; Cells, Cultured; Fluoxetine; In Vitro Techniques; Lysosomes; Neurons; Perazine; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Sertraline; Thioridazine | 2001 |
Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain; Drug Administration Schedule; Fluoxetine; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors | 2002 |
Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation.
Topics: Amitriptyline; Animals; Antidepressive Agents; Cell Death; Cyclic AMP; Desipramine; DNA-Binding Proteins; Early Growth Response Protein 1; Fluoxetine; I-kappa B Proteins; Immediate-Early Proteins; Lysophospholipids; Mitochondria; Mitogen-Activated Protein Kinases; Neurons; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; PC12 Cells; Phosphorylation; Rats; Sphingosine; Transcription Factors | 2002 |
Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.
Topics: Acetylcholinesterase; Adolescent; Adult; Amitriptyline; Antidepressive Agents; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocyte Membrane; Female; Fluoxetine; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
The lack of a placebo effect in a trial of fluoxetine in the treatment of fibromyalgia.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Female; Fibromyalgia; Fluoxetine; Humans; Moclobemide; Placebo Effect; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
[Analysis of psychotropic drug mixtures using high-pressure liquid chromatography in acute poisoning cases].
Topics: Acute Disease; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Codeine; Fluoxetine; Humans; Psychotropic Drugs | 2002 |
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
Topics: Adult; Aged; Amitriptyline; Anti-Bacterial Agents; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clarithromycin; Cohort Studies; Drug Prescriptions; Drug Synergism; Erythromycin; Female; Fluoxetine; Heart Conduction System; Humans; Male; Middle Aged; Ofloxacin; Outpatients; Polypharmacy; Torsades de Pointes; United States | 2003 |
Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Amitriptyline; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Monoamines; Blotting, Western; Carrier Proteins; Culture Techniques; DNA Primers; DNA, Complementary; Drug Interactions; Female; Fluoxetine; Gene Expression Regulation; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Phenols; Piperazines; Pregnancy; Propranolol; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Serotonin; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sulfonamides | 2003 |
An East-West approach to the management of central post-stroke pain.
Topics: Acetates; Acupuncture; Aged; Amines; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol; Triazines | 2003 |
Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Carrageenan; Clomipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Imipramine; Inflammation; Male; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sertraline; Trazodone | 2003 |
[Identification of the drugs in the mixture using thin-layer chromatography in sudden poisoning cases].
Topics: Acute Disease; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chromatography, Thin Layer; Codeine; Data Interpretation, Statistical; Fluoxetine; Humans; Indicators and Reagents; Narcotics; Poisoning; Psychotropic Drugs | 2003 |
[UV spectrophotometric research of drug mixture in sudden poisoning cases].
Topics: Acute Disease; Amitriptyline; Codeine; Data Interpretation, Statistical; Fluoxetine; Humans; Poisoning; Psychotropic Drugs; Research; Spectrophotometry, Ultraviolet | 2003 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Antidepressants and the risk of suicidal behaviors.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents; Case-Control Studies; Child; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; United Kingdom | 2004 |
Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
Topics: Adenosine Triphosphate; Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Bridged Bicyclo Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Fluoresceins; Fluoxetine; Herb-Drug Interactions; Humans; Hypericum; Leukemia; Models, Biological; Phloroglucinol; Plant Extracts; Quercetin; Swine; Terpenes | 2004 |
Antidepressants and the risk of suicidal behaviors.
Topics: Amitriptyline; Antidepressive Agents; Dothiepin; Fluoxetine; Humans; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors; Suicide | 2004 |
Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Cell Survival; Fluoxetine; Hydrogen Peroxide; Oxidants; PC12 Cells; Rats; Superoxide Dismutase | 2005 |
Antidepressants and suicide: a commentary on a significant contribution to this debate.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Depression; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; Time Factors; United Kingdom | 2005 |
Are the effects of the antidepressants amitriptyline, maprotiline, and fluoxetine on inhibitory avoidance state-dependent?
Topics: Amitriptyline; Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Female; Fluoxetine; Inhibition, Psychological; Male; Maprotiline; Mice; Sex Factors | 2006 |
Imputing missing standard deviations in meta-analyses can provide accurate results.
Topics: Amitriptyline; Antidepressive Agents; Data Interpretation, Statistical; Depressive Disorder; Fluoxetine; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic | 2006 |
GABA(B) receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Fluoxetine; Gene Expression; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Male; Pain; Pain Threshold; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Restraint, Physical; Spinal Cord; Stress, Psychological | 2006 |
Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Dose-Response Relationship, Drug; Doxepin; Female; Fibromyalgia; Fluoxetine; Humans; Male; Middle Aged; Neuronal Plasticity; Nociceptors; Pain Threshold; Reference Values; Spinal Cord | 2007 |
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.
Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Pimozide; Rats; Seizures; Status Epilepticus | 2006 |
Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Fluoxetine; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Rheumatology; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome | 2006 |
Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test.
Topics: Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Curcuma; Depression; Dopamine; Ethanol; Fluoxetine; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred ICR; Neurosecretory Systems; Norepinephrine; Phytotherapy; Plant Extracts; Serotonin; Stress, Psychological; Swimming | 2007 |
Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Antidepressive Agents; Aspirin; Drug Therapy; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Retrospective Studies; Sleep Apnea, Obstructive; Sleep, REM; Treatment Refusal | 2006 |
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Investigational; Fluoxetine; Guinea Pigs; Injections, Intraperitoneal; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Swimming; Tranylcypromine | 2007 |
A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder.
Topics: Affective Symptoms; Amitriptyline; Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Brain; Dextromethorphan; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Male; Memantine; Membranes; Radioligand Assay; Rats; Receptors, Neurotransmitter | 2007 |
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression.
Topics: Amitriptyline; Animals; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Conditioning, Operant; Corticosterone; CREB-Binding Protein; Dentate Gyrus; Depressive Disorder, Major; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Heat-Shock Proteins; Hippocampus; Locomotion; Mice; Mice, Inbred C57BL; Molecular Chaperones; Motivation; Selective Serotonin Reuptake Inhibitors | 2008 |
Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats.
Topics: Algorithms; Amitriptyline; Animals; Anti-Anxiety Agents; Fluoxetine; Grooming; Male; Rats; Rats, Wistar | 2008 |
Fibromyalgia remains a controversial medical enigma.
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Fibromyalgia; Fluoxetine; Humans | 2008 |
The inhibition of human neutrophil phagocytosis and oxidative burst by tricyclic antidepressants.
Topics: Amitriptyline; Anesthetics, Local; Antidepressive Agents, Tricyclic; Fluoxetine; Humans; Neutrophils; Nortriptyline; Phagocytosis; Respiratory Burst; Selective Serotonin Reuptake Inhibitors; Staphylococcus aureus | 2008 |
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia.
Topics: Amitriptyline; Antidepressive Agents; Colombia; Convulsive Therapy; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Depressive Disorder; Developing Countries; Drug Costs; Female; Fluoxetine; Health Expenditures; Hospitalization; Humans; Male; Models, Theoretical; Monte Carlo Method; National Health Programs; Office Visits; Psychotherapy; Venlafaxine Hydrochloride | 2008 |
Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Amitriptyline; Animals; Antidepressive Agents; Apoptosis; Cell Culture Techniques; Cell Differentiation; Cell Nucleus; Cell Survival; DNA Fragmentation; Fluoxetine; Membrane Potential, Mitochondrial; Mitochondrial Membranes; Oxidative Stress; PC12 Cells; Permeability; Rats; Tranylcypromine | 2009 |
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2009 |
Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Delphi Technique; Depressive Disorder, Major; Drug Costs; Drugs, Generic; Fluoxetine; Humans; Psychiatric Status Rating Scales; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus.
Topics: Adenylyl Cyclases; Amitriptyline; Animals; Antidepressive Agents; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Isoenzymes; Male; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2009 |
[Effects of amitriptyline, fluoxetine, and tianeptine on the content of monoamines and their metabolites in Wistar rat brain structures].
Topics: Amitriptyline; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Male; Rats; Rats, Wistar; Thiazepines | 2010 |
Resiniferatoxin combined with antidepressants preferentially prolongs sensory/nociceptive block in rat sciatic nerve.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diterpenes; Doxepin; Drug Synergism; Fluoxetine; Male; Nerve Block; Nociceptors; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sensory Receptor Cells | 2010 |
Effects of co-administration of amitriptyline and fluoxetine on inhibitory avoidance in mice.
Topics: Amitriptyline; Animals; Antidepressive Agents; Avoidance Learning; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluoxetine; Male; Mice; Mice, Inbred Strains; Sex Factors | 2010 |
Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depression; Disease Models, Animal; Fluoxetine; Hyperalgesia; Ligation; Male; Mice; Motor Activity; Organoselenium Compounds; Pain Measurement; Sciatic Nerve; Sciatica; Swimming; Time Factors | 2010 |
Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations.
Topics: Amitriptyline; Antidepressive Agents; Bayes Theorem; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Fluoxetine; Humans; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Precision Medicine; Research Design | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Cyclopropanes; Electrodes, Implanted; Fluoxetine; Ligation; Male; Milnacipran; Pain; Pain Management; Pain Measurement; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Spinal Cord; Transcutaneous Electric Nerve Stimulation | 2011 |
Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain.
Topics: Amitriptyline; Amygdala; Animals; Antidepressive Agents; Fluoxetine; Gene Expression Profiling; Hippocampus; Male; Nerve Growth Factor; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Dopamine D5; Receptors, Serotonin, 5-HT3; Receptors, Somatostatin | 2011 |
Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.
Topics: Amitriptyline; Animals; Antidepressive Agents; Aorta, Abdominal; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; Cyclohexanols; Dinoprost; Endothelium, Vascular; Fluoxetine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Phenylephrine; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Inbred Lew; Selective Serotonin Reuptake Inhibitors; Tranylcypromine; Venlafaxine Hydrochloride | 2012 |
CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients.
Topics: Amitriptyline; Antidepressive Agents; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Mexico; Polymorphism, Genetic; Time Factors | 2013 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Removal of trace organic chemical contaminants by a membrane bioreactor.
Topics: Amitriptyline; Bioreactors; Carbamazepine; Diazepam; Diclofenac; Fluoxetine; Gemfibrozil; Omeprazole; Organic Chemicals; Pharmaceutical Preparations; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
Ceramide mediates lung fibrosis in cystic fibrosis.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Ceramides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Fluoxetine; Heterozygote; Interleukin-1; Lung; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Selective Serotonin Reuptake Inhibitors; Sphingomyelin Phosphodiesterase | 2013 |
Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood-brain barrier permeability.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Capillary Permeability; Dogs; Duloxetine Hydrochloride; Fluoxetine; Humans; Imipramine; Madin Darby Canine Kidney Cells; Mianserin; Mirtazapine; Thiophenes; Transfection | 2013 |
Parallel electromembrane extraction in a multiwell plate.
Topics: Amitriptyline; Antipsychotic Agents; Calibration; Chromatography, Liquid; Dibenzothiazepines; Electrochemical Techniques; Ethers; Fluoxetine; Humans; Limit of Detection; Membranes, Artificial; Quetiapine Fumarate; Sertraline; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2014 |
Repetitive injection field-amplified sample stacking for cationic compounds determination.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Calibration; Cations; Electrolytes; Electrophoresis; Electrophoresis, Capillary; Fluoxetine; Humans; Hydrogen-Ion Concentration; Hydroxyzine; Limit of Detection; Opipramol; Phosphoric Acids; Pressure; Promazine; Solvents; Temperature; Thioridazine; Urinalysis | 2014 |
Parallel electromembrane extraction in the 96-well format.
Topics: Amitriptyline; Chromatography, High Pressure Liquid; Electrochemical Techniques; Fluoxetine; Haloperidol; High-Throughput Screening Assays; Humans; Mass Spectrometry; Molecular Structure | 2014 |
Intralipid emulsion treatment as an antidote in lipophilic drug intoxications.
Topics: Adolescent; Adult; Alprazolam; Amitriptyline; Antidotes; Blood Pressure; Dibenzothiazepines; Drug Overdose; Fat Emulsions, Intravenous; Female; Fluoxetine; Glasgow Coma Scale; Heart Rate; Humans; Lamotrigine; Lipid Metabolism; Male; Metoprolol; Middle Aged; Nifedipine; Quetiapine Fumarate; Triazines; Young Adult | 2014 |
The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.
Topics: Amitriptyline; Animals; Antidepressive Agents; Calcium-Binding Proteins; Cyclohexanols; Cyclopropanes; Doxepin; Fluoxetine; Ganglia, Spinal; Hyperalgesia; Male; Microfilament Proteins; Microglia; Milnacipran; Neuralgia; Rats, Wistar; Sciatic Nerve; Spinal Cord; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
[Unpredictable chronic mild stress effects on antidepressants activities in forced swim test].
Topics: Adaptation, Psychological; Amitriptyline; Animals; Antidepressive Agents; Chronic Disease; Drug Administration Schedule; Fluoxetine; Male; Mice; Stress, Psychological; Swimming; Time Factors | 2015 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |
Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclopropanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Milnacipran; Neuralgia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Sulpiride | 2017 |
Global transcriptomic analysis of zebrafish in response to embryonic exposure to three antidepressants, amitriptyline, fluoxetine and mianserin.
Topics: Amitriptyline; Animals; Antidepressive Agents; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation, Developmental; High-Throughput Nucleotide Sequencing; Larva; Mianserin; RNA, Messenger; Sequence Analysis, RNA; Signal Transduction; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2017 |
Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Topics: Amitriptyline; Animals; Drug Interactions; Fluoxetine; HEK293 Cells; Humans; Imipramine; Irinotecan; Mice, Inbred C57BL; Morphine; Narcotics; Ondansetron; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Tissue Distribution; Verapamil | 2018 |
In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Brain; Cell Line, Tumor; Duloxetine Hydrochloride; Fluoxetine; Humans; Mirtazapine; Neoplasm Proteins; Rats; Rats, Sprague-Dawley; Sertraline | 2019 |
Neuronal life or death linked to depression treatment: the interplay between drugs and their stress-related outcomes relate to single or combined drug therapies.
Topics: Amitriptyline; Animals; Antidepressive Agents; Cell Cycle Checkpoints; Depression; Fluoxetine; Hippocampus; Imipramine; Mice; Neurons | 2019 |
Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts.
Topics: Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Coronary Artery Bypass; Endothelium, Vascular; Female; Fluoxetine; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Reference Values; Saphenous Vein; Transplants; Tranylcypromine; Vasodilation; Venlafaxine Hydrochloride | 2019 |
Experimental and Clinical Pharmacokinetics of Fluoxetine and Amitriptyline: Comparative Analysis and Possible Methods of Extrapolation.
Topics: Administration, Oral; Amitriptyline; Animals; Biological Availability; Dogs; Female; Fluoxetine; Humans; Male; Nortriptyline | 2019 |
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs.
Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline | 2019 |
The proliferation effects of fluoxetine and amitriptyline on human breast cancer cells and the underlying molecular mechanisms.
Topics: Amitriptyline; Antidepressive Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estrogen Receptor alpha; Estrogens; Female; Fluoxetine; Humans; MAP Kinase Signaling System; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2021 |
Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress.
Topics: Amitriptyline; Animals; Antidepressive Agents; Fluoxetine; Gastrointestinal Microbiome; Rats; Stress, Psychological | 2021 |
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride | 2021 |
Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
Topics: Adolescent; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Child; Child, Preschool; Drug Prescriptions; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Melatonin; Primary Health Care; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone | 2022 |
The effects of antidepressants fluoxetine, sertraline, and amitriptyline on the development of antibiotic resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amitriptyline; Antidepressive Agents; Drug Resistance, Multiple, Bacterial; Fluoxetine; Humans; Sertraline | 2022 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles.
Topics: Amitriptyline; Animals; Antidepressive Agents; Brain; Ceramides; Desipramine; Endothelial Cells; Extracellular Vesicles; Fluoxetine; Ischemia; Mice; Proteomics | 2022 |
TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli.
Topics: Amitriptyline; Anti-Bacterial Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoxetine; Humans; Microbial Sensitivity Tests; Selective Serotonin Reuptake Inhibitors | 2022 |
The acceptability of antidepressant treatment in people living with HIV in Malawi: A patient perspective.
Topics: Amitriptyline; Antidepressive Agents; Depression; Fluoxetine; HIV Infections; Humans; Malawi; Pilot Projects | 2023 |
Experimental Study of Antidepressant Properties of Afobazole.
Topics: Amitriptyline; Animals; Antidepressive Agents; Fluoxetine; Male; Mice; Mice, Inbred C57BL | 2023 |
The investigation of antidepressant and anxiolytic effects of pregabalin and its mechanisms of action in rats.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Epilepsy; Fluoxetine; Humans; Ketamine; Pregabalin; Rats; Rats, Wistar | 2023 |